Table 3

No interaction between intervention and disease duration, disease activity and medications

Treatment effect, 95% CIP interaction
Time since diagnosis
 <5 years−48.96% (−74.2% to −23.7%)0.322
 >5 years−30.79% (−54.2% to −7.4%)
 SLEDAI-2K
 ≤4−39.66% (−54.0% to −25.3%)0.501
 >4−28.13% (−68.1% to 11.9%)
Corticosteroid use
 No−40.37% (−57.6% to −23.1%)0.722
 Yes−35.46% (−61.1% to −9.8%)
Immunosuppressive agents use
 No−25.16% (−40.2% to 10.11%)0.150
 Yes−48.3% (−77.7% to 18.9%)
  • SLEDAI-2K, systemic lupus erythematosus disease activity index 2000; VAS, Visual Analogue Scale.